EGFR and non-small cell lung carcinoma: In addition, an upregulation of mTOR and Wnt signaling proteins was observed in MET-TKIs/EGFR-TKI-resistant NSCLC cell lines, implying the role of alternative cell signaling pathways in TKI resistance [23].